Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2026-02-20 @ 10:58 PM
Study NCT ID:
NCT05422066
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2022-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
Sponsor:
Organization: